Atlas Trials

An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia

Clinical trial NCT00412620 · TERMINATED

Trial details

NCT number
NCT00412620
Sponsor
Abbott
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2006-12-01
Primary completion
2007-10-01
Enrollment
156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.